Further evidence suggested that the upregulation of β-catenin activity induced by the interaction between MAP4 and GSK3β might be responsible for the pro-migratory and pro-EMT effects of MAP4 on HCC cells. The gene discussed is GSK3B; the disease is hepatocellular carcinoma.